Fingerprint
Dive into the research topics of 'A phase II multicenter study of ipilimumab with or without dacarbazine in chemotherapy-naïve patients with advanced melanoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A phase II multicenter study of ipilimumab with or without dacarbazine in chemotherapy-naïve patients with advanced melanoma
Evan M. Hersh, Steven J. O'Day, John Powderly, Khuda D. Khan, Anna C. Pavlick, Lee D. Cranmer, Wolfram E. Samlowski, Geoffrey M. Nichol, Michael J. Yellin, Jeffrey S. Weber
Research output: Contribution to journal › Article › peer-review
273
Scopus
citations